Praxis Precision Medicines to Showcase Innovations This Fall
Upcoming Investor Conferences for Praxis Precision Medicines
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a dynamic entity in the field of biopharmaceuticals, has an exciting roster of events lined up this fall. The company is dedicated to developing therapies aimed at addressing central nervous system (CNS) disorders that are driven by imbalances in neuronal excitation and inhibition. Their focus on leveraging genetic insights is positioning them at the forefront of advancements in treatment for these complex conditions.
Schedule of Presentations
Baird 2025 Global Healthcare Conference
Mark your calendars for Tuesday, when Praxis will present at the Baird 2025 Global Healthcare Conference. Set for 9:00-9:35am EDT, the event will be held at the InterContinental New York Barclay. This will offer a platform for Praxis to connect with investors and share their vision for the future of neurological therapeutics.
H.C. Wainwright 27th Annual Global Investment Conference
The following day, on Wednesday, at 8:30am EDT, Praxis will participate in a fireside chat at the H.C. Wainwright Global Investment Conference, held at the luxurious Lotte New York Palace Hotel. Investors will have the opportunity to gain insightful perspectives from the management team and engage with the company's strategic goals during this discussion. For those unable to attend in person, a live webcast of this discussion will be accessible online.
TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
On Thursday, Praxis will also be part of the TD Cowen summit, participating in a virtual presentation scheduled for 3:00-3:30pm EDT. This summit will emphasize the innovative frameworks Praxis is implementing in the management of neuropsychiatric conditions and epilepsy, further demonstrating their commitment to improving patient outcomes.
Networking Opportunities for Investors
Throughout these conferences, Praxis Management will be available for one-on-one meetings. Investors interested in engaging directly with the company's leadership are encouraged to reach out through their respective representatives to arrange meetings. This personal approach allows for meaningful dialogue, ensuring investors can connect questions and insights directly with the team driving the company forward.
Webcast Replay Availability
For those who cannot attend, there will be a replay of the webcast from these events. It will be available for a period of 90 days and can be found on the company’s dedicated ‘Events & Presentations’ page under the ‘Investors + Media’ section of their official website.
About Praxis Precision Medicines
Praxis Precision Medicines is pioneering the transformation of genetic insights into viable treatments for CNS disorders marked by neuronal excitation-inhibition imbalances. Their work focuses on both rare and more common neurological disorders via a proprietary platform named Cerebrum™, along with the Solidus™ antisense oligonucleotide technology. With a robust network of clinical-stage candidates, including four differentiated programs targeting challenges in epilepsy and movement disorders, Praxis is committing extensive resources to optimizing therapeutic approaches. To learn more about their research and initiatives, you can visit their website at www.praxismedicines.com, and stay updated by following their social media handles across platforms like Facebook, Instagram, LinkedIn, and Twitter.
Frequently Asked Questions
What are the key events Praxis Precision Medicines is attending?
Praxis will attend the Baird 2025 Global Healthcare Conference, H.C. Wainwright Global Investment Conference, and TD Cowen 5th Annual Summit.
When will Praxis present at the Baird Conference?
The presentation at the Baird 2025 Conference is scheduled for September 9th at 9:00-9:35am EDT.
How can investors contact Praxis for meetings?
Investors can reach out through their respective representatives to schedule one-on-one meetings during the conferences.
What technology platforms does Praxis use?
Praxis utilizes their Cerebrum™ platform for small molecule therapies and Solidus™ for antisense oligonucleotide applications.
How can I access the webcast of the events?
The recorded webcasts will be available on Praxis's 'Events & Presentations' page on their website for 90 days post-event.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.